MovDisordV3, Ncbi, Merge, bibRecord, 000742

Suppression of cortical myoclonus by levetiracetam.

Identifieur interne : 000742 ( Ncbi/Merge ); précédent : 000741; suivant : 000743

Suppression of cortical myoclonus by levetiracetam.

Auteurs : Robert Schauer [Autriche] ; Markus Singer ; Leopold Saltuari ; Markus Kofler

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2002.

RBID : pubmed:11921136

English descriptors

KwdEn :
- Adolescent, Anticonvulsants (adverse effects), Anticonvulsants (therapeutic use), Cerebral Cortex (drug effects), Cerebral Cortex (injuries), Dominance, Cerebral (physiology), Drug Therapy, Combination, Epilepsy, Post-Traumatic (diagnosis), Epilepsy, Post-Traumatic (drug therapy), Humans, Male, Myoclonic Epilepsy, Juvenile (diagnosis), Myoclonic Epilepsy, Juvenile (drug therapy), Piracetam (adverse effects), Piracetam (analogs & derivatives), Piracetam (therapeutic use).
MESH :
- chemical , adverse effects : Anticonvulsants, Piracetam.
- chemical , analogs & derivatives : Piracetam.
- chemical , therapeutic use : Anticonvulsants, Piracetam.
- diagnosis : Epilepsy, Post-Traumatic, Myoclonic Epilepsy, Juvenile.
- drug effects : Cerebral Cortex.
- drug therapy : Epilepsy, Post-Traumatic, Myoclonic Epilepsy, Juvenile.
- injuries : Cerebral Cortex.
- physiology : Dominance, Cerebral.
- Adolescent, Drug Therapy, Combination, Humans, Male.

Abstract

A 16-year-old boy suffered severely disabling posthypoxic myoclonus. Neurophysiological investigation showed cortical but not reticular reflex myoclonus. Add-on therapy with levetiracetam significantly improved the patient's clinical condition, suppressed cortical myoclonus-associated spikes, and enabled further neurorehabilitation.

PubMed: 11921136

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003B09
to stream PubMed, to step Curation: 003B09
to stream PubMed, to step Checkpoint: 003922

Links to Exploration step

pubmed:11921136

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Suppression of cortical myoclonus by levetiracetam.</title>
<author><name sortKey="Schauer, Robert" sort="Schauer, Robert" uniqKey="Schauer R" first="Robert" last="Schauer">Robert Schauer</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Hospital Hochzirl, Zirl, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, Hospital Hochzirl, Zirl</wicri:regionArea>
<wicri:noRegion>Zirl</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Singer, Markus" sort="Singer, Markus" uniqKey="Singer M" first="Markus" last="Singer">Markus Singer</name>
</author>
<author><name sortKey="Saltuari, Leopold" sort="Saltuari, Leopold" uniqKey="Saltuari L" first="Leopold" last="Saltuari">Leopold Saltuari</name>
</author>
<author><name sortKey="Kofler, Markus" sort="Kofler, Markus" uniqKey="Kofler M" first="Markus" last="Kofler">Markus Kofler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:11921136</idno>
<idno type="pmid">11921136</idno>
<idno type="wicri:Area/PubMed/Corpus">003B09</idno>
<idno type="wicri:Area/PubMed/Curation">003B09</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003922</idno>
<idno type="wicri:Area/Ncbi/Merge">000742</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Suppression of cortical myoclonus by levetiracetam.</title>
<author><name sortKey="Schauer, Robert" sort="Schauer, Robert" uniqKey="Schauer R" first="Robert" last="Schauer">Robert Schauer</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Hospital Hochzirl, Zirl, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, Hospital Hochzirl, Zirl</wicri:regionArea>
<wicri:noRegion>Zirl</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Singer, Markus" sort="Singer, Markus" uniqKey="Singer M" first="Markus" last="Singer">Markus Singer</name>
</author>
<author><name sortKey="Saltuari, Leopold" sort="Saltuari, Leopold" uniqKey="Saltuari L" first="Leopold" last="Saltuari">Leopold Saltuari</name>
</author>
<author><name sortKey="Kofler, Markus" sort="Kofler, Markus" uniqKey="Kofler M" first="Markus" last="Kofler">Markus Kofler</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Anticonvulsants (adverse effects)</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Cerebral Cortex (drug effects)</term>
<term>Cerebral Cortex (injuries)</term>
<term>Dominance, Cerebral (physiology)</term>
<term>Drug Therapy, Combination</term>
<term>Epilepsy, Post-Traumatic (diagnosis)</term>
<term>Epilepsy, Post-Traumatic (drug therapy)</term>
<term>Humans</term>
<term>Male</term>
<term>Myoclonic Epilepsy, Juvenile (diagnosis)</term>
<term>Myoclonic Epilepsy, Juvenile (drug therapy)</term>
<term>Piracetam (adverse effects)</term>
<term>Piracetam (analogs & derivatives)</term>
<term>Piracetam (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anticonvulsants</term>
<term>Piracetam</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Piracetam</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term>
<term>Piracetam</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Epilepsy, Post-Traumatic</term>
<term>Myoclonic Epilepsy, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cerebral Cortex</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Epilepsy, Post-Traumatic</term>
<term>Myoclonic Epilepsy, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="injuries" xml:lang="en"><term>Cerebral Cortex</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Dominance, Cerebral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A 16-year-old boy suffered severely disabling posthypoxic myoclonus. Neurophysiological investigation showed cortical but not reticular reflex myoclonus. Add-on therapy with levetiracetam significantly improved the patient's clinical condition, suppressed cortical myoclonus-associated spikes, and enabled further neurorehabilitation.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">11921136</PMID>
<DateCreated><Year>2002</Year>
<Month>03</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>05</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>17</Volume>
<Issue>2</Issue>
<PubDate><Year>2002</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Suppression of cortical myoclonus by levetiracetam.</ArticleTitle>
<Pagination><MedlinePgn>411-5</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A 16-year-old boy suffered severely disabling posthypoxic myoclonus. Neurophysiological investigation showed cortical but not reticular reflex myoclonus. Add-on therapy with levetiracetam significantly improved the patient's clinical condition, suppressed cortical myoclonus-associated spikes, and enabled further neurorehabilitation.</AbstractText>
<CopyrightInformation>Copyright 2002 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schauer</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Hospital Hochzirl, Zirl, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Singer</LastName>
<ForeName>Markus</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Saltuari</LastName>
<ForeName>Leopold</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kofler</LastName>
<ForeName>Markus</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>230447L0GL</RegistryNumber>
<NameOfSubstance UI="C026098">etiracetam</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>ZH516LNZ10</RegistryNumber>
<NameOfSubstance UI="D010889">Piracetam</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004292">Dominance, Cerebral</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004834">Epilepsy, Post-Traumatic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020190">Myoclonic Epilepsy, Juvenile</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010889">Piracetam</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11921136</ArticleId>
<ArticleId IdType="pii">10.1002/mds.10027</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Autriche</li>
</country>
</list>
<tree><noCountry><name sortKey="Kofler, Markus" sort="Kofler, Markus" uniqKey="Kofler M" first="Markus" last="Kofler">Markus Kofler</name>
<name sortKey="Saltuari, Leopold" sort="Saltuari, Leopold" uniqKey="Saltuari L" first="Leopold" last="Saltuari">Leopold Saltuari</name>
<name sortKey="Singer, Markus" sort="Singer, Markus" uniqKey="Singer M" first="Markus" last="Singer">Markus Singer</name>
</noCountry>
<country name="Autriche"><noRegion><name sortKey="Schauer, Robert" sort="Schauer, Robert" uniqKey="Schauer R" first="Robert" last="Schauer">Robert Schauer</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000742 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000742 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:11921136
   |texte=   Suppression of cortical myoclonus by levetiracetam.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:11921136" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Suppression of cortical myoclonus by levetiracetam.

Suppression of cortical myoclonus by levetiracetam.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki